Literature DB >> 27002552

Visual Functioning and Health-related Quality-of-Life are Compromised in Patients with Uveitis.

Michelle M Hui1, Denis Wakefield1,2, Ilesh Patel3, Erin Cvejic4, Peter J McCluskey1,2,5, John H Chang1,6,7.   

Abstract

PURPOSE: To assess the vision-related (VR) and health-related (HR) quality-of-life (QoL) of patients with uveitis.
METHODS: In total, 60 patients with uveitis, 81 patients with diabetic retinopathy (DR), and 70 healthy subjects completed the National Eye Institute Visual Functioning Questionnaire and the Medical Outcome Study 36-Item Short Form.
RESULTS: Patients with uveitis reported lower HR- and VR-QoL than healthy subjects (p<0.05) and lower VR-QoL (p<0.001) than patients with DR. For patients with uveitis, multiple linear regression analyses indicated that lower HR-QoL scores were predicted by younger age (p<0.01), while lower VR-QoL scores were predicted by poorer visual acuity (p<0.001), ocular comorbidities (p<0.05), and female sex (p<0.05).
CONCLUSIONS: Patients with uveitis have significantly poorer VR- and HR-QoL than healthy control subjects. Uveitis has a more debilitating impact on VR-QoL than DR.

Entities:  

Keywords:  Diabetic retinopathy; ocular inflammation; quality-of-life; uveitis

Mesh:

Year:  2016        PMID: 27002552     DOI: 10.3109/09273948.2016.1139734

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  8 in total

1.  Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.

Authors:  John Sheppard; Avani Joshi; Keith A Betts; Stacie Hudgens; Samir Tari; Naijun Chen; Martha Skup; Andrew D Dick
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

2.  Time Trade-off Utility Values in Noninfectious Uveitis.

Authors:  Katherine M Niemeyer; John A Gonzales; Thuy Doan; Erica N Browne; Maya M Rao; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2019-06-13       Impact factor: 5.258

3.  Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis.

Authors:  Katherine M Niemeyer; John A Gonzales; Sivakumar R Rathinam; Manohar Babu; Radhika Thundikandy; Anuradha Kanakath; Travis C Porco; Erica N Browne; Maya M Rao; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2017-04-14       Impact factor: 5.258

4.  Incidence and changing patterns of uveitis in Central Tokyo.

Authors:  Takafumi Suzuki; Toshikatsu Kaburaki; Rie Tanaka; Shintaro Shirahama; Keiko Komae; Hisae Nakahara; Mitsuko Takamoto; Hidetoshi Kawashima; Makoto Aihara
Journal:  Int Ophthalmol       Date:  2021-05-28       Impact factor: 2.031

5.  Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.

Authors:  Nicole K Kelly; Aheli Chattopadhyay; S R Rathinam; John A Gonzales; Radhika Thundikandy; Anuradha Kanakath; S Bala Murugan; R Vedhanayaki; Dean Cugley; Lyndell L Lim; Eric B Suhler; Hassan A Al-Dhibi; Caleb D Ebert; Elyse J Berlinberg; Travis C Porco; Nisha R Acharya
Journal:  Ophthalmology       Date:  2021-03-04       Impact factor: 14.277

6.  Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer's perspective.

Authors:  Seenu M Hariprasad; George Joseph; Patrick Gagnon-Sanschagrin; Elizabeth Serra; Subrata Bhattacharyya; Jérôme Bédard; Annie Guérin; Thomas Arno Albini
Journal:  BMJ Open Ophthalmol       Date:  2021-11-10

7.  Outcomes in patients with chronic uveitis: which factors matter to patients? A qualitative study.

Authors:  Aline C Stolk-Vos; Hamasa Kasigar; Karlijn J Nijmeijer; Tom O Missotten; Jan J Busschbach; Joris J van de Klundert; Leonieke W Kranenburg
Journal:  BMC Ophthalmol       Date:  2020-03-30       Impact factor: 2.209

8.  Anxiety and depression in inflammatory eye disease: exploring the potential impact of topical treatment frequency as a putative psychometric item.

Authors:  Georgios Vakros; Paolo Scollo; James Hodson; Philip I Murray; Saaeha Rauz
Journal:  BMJ Open Ophthalmol       Date:  2021-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.